International Drug Mart

What is this pill? Tannish peach color, elliptical, marked 10 MG and 5 dots in a small box?

Zolpidem tartate pill identification
E
Written by
Emily Harris
Dr. Cole Mercer, MD
Medically Reviewed by
Dr. Cole Mercer, MD
Last Updated On

Some patients are caregivers are often known to make the first round of identification of tablets by appearance and certain indications, following which the final identification is carried out. Certain tablets come with distinctive markings and colors, and this helps differentiate between tablets, and are also useful when taken in a sequence. Here’s a question to jog the memory of patients - what is this pill? Tannish peach color, elliptical, marked 10 MG and 5 dots in a small box? Well, if the answer is elusive, here is the right answer - Zolpidem Tartrate. Following subsections offer a detailed look at the medication, its uses and effects.

Overview of Zolpidem Tartrate

Treatment for insomnia includes the use of Zolpidem tartrate, belonging to the class of drugs known as sedative-hypnotics. Used mainly as a short-term treatment option to help people who have difficulty falling asleep or staying asleep at night, it works by acting on receptors in the brain promoting sleep. The drug is available under various brand names, including Ambien, Edluar, and Intermezzo. Available as a tablet or sublingual tablet it is generally recommended to be used no longer than 10 days. This is mainly to minimize the risk of dependence and other potential side effects. Zolpidem tartrate is only to be taken as prescribed by a healthcare professional, as per recommended dosage.

What is the ideal dosage of Zolpidem Tartrate?

The ideal dosage of zolpidem tartrate, depends on various factors, including the individual's age, health condition, medical history, and response to the medication. The following information is mainly for the purpose of reference, regarding the maximum permitted dosage, and is not a substitute for medical advice.

  • For adults, the typical starting dosage of zolpidem tartrate for insomnia is 5 mg of immediate-release formulations such as Ambien and 6.25 mg for extended-release tablets, such as Ambien CR. These doses are usually taken right before bedtime, and should not be taken with or immediately after a meal, as food can delay the onset of action of the medication. In certain instances, the dosage of zolpidem tartrate may be adjusted as per the response and tolerance of the patient. However, the general recommendation is to use the lowest effective dose for the shortest duration possible to minimize the risk of side effects, including dependence and withdrawal symptoms.
  • For elderly patients, the recommended starting dosage of zolpidem tartrate is usually lower, typically 5 mg for immediate-release tablets and 6.25 mg for extended-release tablets. This is mainly to factor in the potential increased sensitivity to the medication.

It is also important to diligently follow tapering instructions if the medication needs to be discontinued, as abrupt cessation can result in withdrawal symptoms.

Mechanism of action of Zolpidem Tartrate

The sedative-hypnotic medication works by binding to a specific type of receptor in the brain - the gamma-aminobutyric acid (GABA) type A receptor. These receptors are responsible for inhibiting the activity of neurons in the central nervous system, reducing neuronal activity and promoting sleep. Zolpidem tartrate is a selective agonist that binds to a specific subset of GABA type A receptors known as the alpha-1 receptors, primarily located in the brain regions involved in regulation of sleep and wakefulness. By binding to these receptors, zolpidem tartrate enhances the inhibitory effects of GABA, resulting in an overall decrease in CNS activity, promoting sleep initiation and maintenance.

Zolpidem tartrate possesses the ability to bring about increased chloride ion influx into the neurons, hyperpolarization of the neuronal membrane, and ultimately inhibit neuronal activity. This brings about a calming effect on the brain, inducing and maintaining sleep. The medication has a relatively short half-life, with a rapid onset of action and a short duration of effect. This makes it suitable for short-term treatment of insomnia, and is not considered to be ideal for long-term use mainly due to possible dependence and tolerance.

Side effects of Zolpidem Tartrate

All medications are known to cause undesirable outcomes, and Zolpidem tartrate is no exception. Commonly reported side effects of zolpidem tartrate are as listed below. It is important to note that all patients are unlikely to experience the effects, with only a section of users experiencing the adverse outcomes, with some free from all side effects.

  • Drowsiness: As a sedative, the medication may cause and drowsiness, impairing coordination and reaction time, and possibly increasing the risk of falls or accidents, especially in elderly patients.
  • Dizziness: Similarly, the drug can cause dizziness, impacting balance and coordination, resulting in an increased risk of falls.
  • Headache: Some patients are likely to experience headaches as a side effect of zolpidem tartrate.
  • Nausea and vomiting: The drug may cause gastrointestinal symptoms such as nausea and vomiting.
  • Daytime drowsiness: Residual daytime drowsiness, is another possible side effect, affecting alertness and cognitive functions on the following the day after intake of the medication.
  • Memory problems: It is also likely to cause memory problems, including anterograde amnesia, which is difficulty forming new memories, particularly if the medication is not taken as directed or when taken in higher doses.
  • Sleep-related behaviors: In rare instances, zolpidem tartrate is linked to sleep-related behaviors, such as sleepwalking, sleep driving, and other complex behaviors that are performed while asleep and may have no recollection of afterwards.
  • Mood changes: Sudden changes in mood, agitation, and even paradoxical reactions such as increased anxiety or agitation are likely to manifest in some individuals.
  • Respiratory depression: Like most sedative-hypnotics, the drug can depress the respiratory system, particularly when taken in higher doses or in combination with other central nervous system depressants. This can be potentially dangerous, especially in individuals with respiratory conditions.
  • Allergic reactions: Though rare, zolpidem tartrate is also known to cause allergic reactions, such as rashes, swelling, and difficulty breathing, that require immediate medical attention.

Possible drug interactions of Zolpidem Tartrate

In addition to side effects, the drug may also interact with other drugs and substances, potentially resulting in adverse effects or reducing the effectiveness of one or both medications. The treating specialist is to be informed of all medications, supplements, and substances in use, including prescription, over-the-counter, and herbal products, to minimize the risk of drug interactions. Possible drug interactions include the following:

  • Central nervous system depressants: When used in combination with other central nervous system depressants, such as benzodiazepines, opioids, barbiturates, or alcohol, the drug can increase the risk of excessive sedation, respiratory depression, and other adverse effects.
  • Antidepressants: Certain antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), may interact with zolpidem tartrate and increase the risk of adverse effects, such as excessive sedation, confusion, and serotonin syndrome, a potentially life-threatening condition.
  • Antipsychotics: Certain antipsychotic medications may interact with zolpidem tartrate and increase the risk of sedation, cognitive impairment, and other adverse effects.
  • Muscle relaxants: Zolpidem tartrate may also enhance the effects of muscle relaxants, leading to increased muscle relaxation and sedation.
  • CYP3A4 inhibitors: Zolpidem tartrate is metabolized in the liver by the enzyme CYP3A4, and medications that are known to have an inhibitory effect on this enzyme, such as ketoconazole, itraconazole, and clarithromycin, may increase the levels of zolpidem tartrate in the bloodstream, resulting in increased sedation and other adverse effects.
  • CYP3A4 inducers: Similarly, drugs that have the opposite effect - inducers of CYP3A4, such as rifampin, carbamazepine, and St. John's Wort, may decrease the levels of zolpidem tartrate in the bloodstream, potentially reducing its effectiveness.

Herbal supplements: Some herbal supplements, such as valerian root and kava, may have sedative effects and may interact with zolpidem tartrate, increasing the risk of excessive sedation

Order prescription medicines onlineTrusted pharmacy – wide range of medications available
USE CODEIDMBLG30Save up to 30%